Trial Committee - Neo-ACT

• Jana de Boniface (National Coordinating Investigator), Associate Professor, Department of Molecular Medicine and Surgery, L1:00, Karolinska Institutet 17176 Stockholm or Department of Surgery, Capio St. Göran’s Hospital, Stockholm.
• Yvonne Wengström (Coordinating Investigator exercise), Professor, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm.
• Renske Altena (Coordinating Investigator oncology/toxicity/translational research), PhD, Medical Unit Breast, Endocrine Tumours and Sarcoma, Theme Cancer, Karolinska University Hospital, Department of Oncology Pathology, Karolinska Institutet, Stockholm.
• Cecilia Haddad Ringborg (postdoc, coordinator exercise), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm
• Peeter Karihtala (national coordinator Finland), Professor, Research Director at Helsinki University Hospital, Comprehensive Cancer Center, Finland
• Frankie Brown (national coordinator Scotland), PhD, Lecturer in Exercise Physiology, Sport, Health & Exercise Sciences (SEHS), School of Applied Sciences, Edinburgh Napier University, Scotland
• Eva Zopf (national coordinator Australia), PhD, Exercise Scientist and Head of the Cancer Exercise Lab, Cabrini Cancer Institute, Cabrini Health, Melbourne, Australia
• Marios Tasoulis (national coordinator UK/England), MD, PhD, Consultant Oncoplastic Breast Surgeon & Honorary Clinical Senior Lecturer, The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research, London, UK
• Elena Leinert (national coordinator Germany), MD, Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany
• Thorsten Kühn (national coordinator Germany), professor, chairman of EUBREAST, University of Ulm and Die Filderklinik, Germany

Advisory board

• Johan Hartman (pathology), Professor, Karolinska Institutet, Dept. of Oncology-Pathology
• Sophia Zackrisson (radiology), Professor, Skåne University Hospital Malmö and Lund University
• Robert Szulkin (trial statistician), PhD, Scandinavian Development Services, Danderyd, Sweden
• Åsa Magnusson (patient representative), Swedish Breast Cancer Association (Bröstcancerförbundet)"

Data Safety Monitoring Board (DSMB)

• Beatrice Melin, Professor, Department of Diagnostics and Intervention, Umeå University
• John Öhrvik, Professor, Centre for Clinical Research, County of Västmanland
• Eva Haglind, Professor Emerita, Department of Surgery, Sahlgrenska University hospital